FIELD: biotechnology.
SUBSTANCE: group of inventions relates to peptides for producing an antibody specifically bound to human IL-13, as well as to an application thereof for producing such antibody. Proposed is a peptide for producing an antibody specifically bound to human IL-13, consisting substantially of an amino acid sequence ESLINVSG (SEQ ID NO:18). Also proposed is a peptide for producing an antibody specifically bound to human IL-13, consisting substantially of an amino acid sequence YCAALESLINVS (SEQ ID NO:19).
EFFECT: described peptides can be applied in producing an antibody specifically bound to human IL-13.
3 cl, 11 ex, 21 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIBODY-LIKE BINDING PROTEINS WITH DOUBLE VARIABLE REGIONS HAVING CROSS-CROSS ORIENTATION OF BINDING REGIONS | 2012 |
|
RU2823693C2 |
| IL4/IL13 RECEPTOR MOLECULE FOR VETERINARY USE | 2018 |
|
RU2795591C2 |
| T- CELLS WITH COSTIMULATING CHIMERIC ANTIGEN RECEPTOR TARGETING IL13Rα2 | 2015 |
|
RU2749922C2 |
| PSEUDO-FAB BASED MULTISPECIFIC BINDING PROTEINS | 2019 |
|
RU2820254C2 |
| ANTI-LILRB1 ANTIBODY AND USES THEREOF | 2021 |
|
RU2813373C1 |
| ANTI-LILRB1 ANTIBODY AND ITS USE | 2020 |
|
RU2801535C1 |
| NEW ANTI-C-MET-ANTIBODY AND APPLICATION THEREOF | 2018 |
|
RU2751720C2 |
| MOLECULES TARGETING A TYPE III SECRETION SYSTEM | 2016 |
|
RU2759949C2 |
| ANTIBODIES BINDING TO HUMAN CANNABINOID RECEPTOR 1 (CB1) | 2015 |
|
RU2730674C2 |
| ANTIBODY CAPABLE OF BINDING TO THYMIC STROMAL LYMPHOPOIETIN, AND USE THEREOF | 2020 |
|
RU2825304C2 |
